1. Home
  2. EDAP vs SERA Comparison

EDAP vs SERA Comparison

Compare EDAP & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • SERA
  • Stock Information
  • Founded
  • EDAP 1979
  • SERA 2008
  • Country
  • EDAP France
  • SERA United States
  • Employees
  • EDAP N/A
  • SERA N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SERA Precision Instruments
  • Sector
  • EDAP Health Care
  • SERA Health Care
  • Exchange
  • EDAP Nasdaq
  • SERA Nasdaq
  • Market Cap
  • EDAP 75.5M
  • SERA 90.6M
  • IPO Year
  • EDAP 1997
  • SERA 2021
  • Fundamental
  • Price
  • EDAP $2.00
  • SERA $2.74
  • Analyst Decision
  • EDAP Buy
  • SERA
  • Analyst Count
  • EDAP 3
  • SERA 0
  • Target Price
  • EDAP $8.50
  • SERA N/A
  • AVG Volume (30 Days)
  • EDAP 81.7K
  • SERA 44.4K
  • Earning Date
  • EDAP 11-06-2025
  • SERA 11-13-2025
  • Dividend Yield
  • EDAP N/A
  • SERA N/A
  • EPS Growth
  • EDAP N/A
  • SERA N/A
  • EPS
  • EDAP N/A
  • SERA N/A
  • Revenue
  • EDAP $74,853,925.00
  • SERA $108,000.00
  • Revenue This Year
  • EDAP N/A
  • SERA $217.92
  • Revenue Next Year
  • EDAP N/A
  • SERA $479.25
  • P/E Ratio
  • EDAP N/A
  • SERA N/A
  • Revenue Growth
  • EDAP 0.61
  • SERA 0.94
  • 52 Week Low
  • EDAP $1.21
  • SERA $1.37
  • 52 Week High
  • EDAP $3.05
  • SERA $9.13
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 45.90
  • SERA 36.63
  • Support Level
  • EDAP $1.82
  • SERA $2.30
  • Resistance Level
  • EDAP $2.24
  • SERA $3.21
  • Average True Range (ATR)
  • EDAP 0.21
  • SERA 0.28
  • MACD
  • EDAP -0.02
  • SERA -0.11
  • Stochastic Oscillator
  • EDAP 46.38
  • SERA 21.21

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: